Healthcare >> CEO Interviews >> October 12, 2001
DR. MITCHELL S. STEINER is Founder, Vice Chairman and Chief Executive
Officer of GTx, Inc., which was formed in September 1997. Dr. Steiner
presently serves as the Vice Chairman and Chief Executive Officer of the
company. He received his MD from The University of Tennessee in 1986. He
trained in Surgery and Urology and Molecular Biology at the Johns
Hopkins School of Medicine. He also obtained a Molecular Biology
Postdoctoral Fellowship as an American Foundation for Urologic Disease
Scholar from Vanderbilt University from 1986'1995 and simultaneously had
an appointment as Assistant Professor of Urology, Cell Biology and
Pathology. He has served as the Chairman and Professor of the Department
of Urology, Professor of Pharmacology, Director of Urologic Oncology and
Research, Chair of Excellence in Urologic Oncology, at The University of
Tennessee, Memphis. Dr. Steiner is Board Certified in Urology (February
1997) and a Fellow of the American College of Surgeons (October 2000).
Dr. Steiner is a member of the American Gene Therapy Society, American
Association for Cancer Research, American Urological Society, Society
for Basic Urology Research, Society for Urologic Oncology, and other
prestigious societies. Dr. Steiner has conducted independent laboratory
cancer research since 1980 and has been a recipient of NIH RO1s,
Department of Defense, and CAPCURE Grants. He was a member of the Cancer
Leukemia Group B Intergroup study section. He serves as a member of the
Editorial Board of Gene Therapy and Molecular Biology Journal, Editor-
in-Chief of the World Journal of Urology, Section Editor of the Prostate
Cancer section of Current Opinions in Urology, and was a member of the
NIH. Profile
of GTx, Inc?
Dr. Steiner: Our company was founded in September 1997 and has unique
technology platforms that are focused
